Del.icio.us
Google
Yahoo MyWeb
Facebook
TransPharma Medical Overview
Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transdermal drug delivery technology. We are currently pursuing two proprietary drug-product development programs: ViaDerm-hPTH (1-34), a transdermal hPTH (1-34) product to treat osteoporosis; and ViaDerm-hGH, a...More»
Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transdermal drug delivery technology. We are currently pursuing two proprietary drug-product development programs: ViaDerm-hPTH (1-34), a transdermal hPTH (1-34) product to treat osteoporosis; and ViaDerm-hGH, a transdermal human growth hormone (hGH) drug product to treat human growth hormone deficient patients. Our development programs are in advanced clinical studies and results have been extremely promising.
TransPharma’s goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. We believe that through this mix of partnered and proprietary product development, we are capitalizing both on the promise of our technology and our growing capabilities.«Less
Key People
Board of Directors
Advisors
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 07/2006 | Series C | 18M | Unknown |
Products
| Name: | ViaDerm System |
| Product URL: | http://www.transpharma-medical.com/viaderm_system.html |
| Description: | TransPharma Medical’s application of its RF-MicroChannel Technology is the ViaDerm drug delivery system. Intended for home use, the system consists of a reusable battery-operated handheld electronic control unit, a disposable low-cost microelectrode array and a patch containing a drug. The reusable device, with disposable microelectrode array attached, creates the RF MicroChannels. This prepares the site for application of a proprietary patch containing a drug. The drug is than passively diffused through the RF-MicroChannels into the inner skin layer and from there to the systemic circulation. The ViaDerm system is designed for continuous, one-handed application. |
| Screenshots: |
|
Competitors
Profile
OpinionsRelated Companies
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »
Similar Companies
View All Similar »Web Metrics
View All Web Metrics »
| Alexa Rank: | 7778996 |  |
3263323 |
| Yahoo Search Results: | 2,790 | ||
TransPharma Medical on Twitter
Twitter Search »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.
Related Jobs
loading...